ADPT- Adaptive Biotechnologies Corporation

Name: Adaptive Biotechnologies Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robins Chad M	2.18M	$51.93M	-
Other	Bobulsky Susan	401.3K	$9.56M	-5,000
CFO	Piskel Kyle	256.7K	$6.11M	-
Other	Lo Francis	230.7K	$5.49M	-105,762
Other	Benzeno Sharon	113.5K	$2.70M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 21, 2026	Robins Harlan S83	Chief Scientific Officer	Sale+OE	492,400	$21.89	$10,780,408.80	-21.1%	-	-
Jul 16, 2026	Bobulsky Susan	Chief Commercial Officer, Mrd	Sell	5,000	$23.00	$115,000.00	-1.2%	-	-
Jul 15, 2026	Lo Francis78	Chief People Officer	Sale+OE	105,762	$22.59	$2,389,163.58	-31.4%	-	-
Jul 2, 2026	Robins Harlan S83	Chief Scientific Officer	Sell	386,240	$22.01	$8,501,148.79	-15.0%	-	-
Jul 2, 2026	Lo Francis78	Chief People Officer	Sale+OE	95,842	$22.51	$2,157,682.66	-11.4%	-	-
Jul 1, 2026	Bobulsky Susan	Chief Commercial Officer, Mrd	Sell	487	$22.00	$10,714.00	-0.1%	-	-
Jun 29, 2026	Benzeno Sharon78	Chief Commercial Ofc Imm Med	Sale+OE	165,802	$21.13	$3,503,509.52	-25.1%	-	-
Jun 25, 2026	Griffin Michelle Renee80	Director	Sale+OE	52,084	$20.18	$1,051,055.12	-76.9%	-	-
Jun 25, 2026	Bobulsky Susan	Chief Commercial Officer, Mrd	Sell	5,000	$20.50	$102,500.00	-1.2%	-	-
Jun 16, 2026	Robins Harlan S83	Chief Scientific Officer	Sell	106,160	$17.41	$1,847,941.60	-3.6%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC